NasdaqCM - Nasdaq Real Time Price USD
Edesa Biotech, Inc. (EDSA)
As of 10:14 AM EST. Market Open.
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
--
--
--
--
328.8010
Cost of Revenue
--
--
--
--
17.6010
Gross Profit
--
--
--
--
311.2000
Operating Expense
7,137.9100
8,641.7190
17,590.5330
13,340.4930
6,712.0420
Operating Income
-7,137.9100
-8,641.7190
-17,590.5330
-13,340.4930
-6,400.8420
Net Non Operating Interest Income Expense
208.9520
289.8460
63.5230
11.1650
37.7780
Other Income Expense
1.4210
-21.7420
-21.1140
-13.0220
-0.3660
Pretax Income
-6,927.5370
-8,373.6150
-17,548.1240
-13,342.3500
-6,363.4300
Tax Provision
0.8000
0.8000
0.8000
0.8000
0.8000
Net Income Common Stockholders
-6,928.3370
-8,374.4150
-17,548.9240
-13,343.1500
-6,364.2300
Diluted NI Available to Com Stockholders
-6,928.3370
-8,374.4150
-17,548.9240
-13,343.1500
-6,364.2300
Basic EPS
-19.78
-20.51
-7.35
-7.70
-5.18
Diluted EPS
-19.78
-20.51
-7.35
-7.70
-5.18
Basic Average Shares
691.8080
408.4180
2,380.2870
1,725.4030
1,229.5940
Diluted Average Shares
691.8080
408.4180
2,380.2870
1,725.4030
1,229.5940
Total Operating Income as Reported
-8,380.0110
-9,222.7580
-18,370.7900
-23,681.3320
-6,400.8420
Total Expenses
7,137.9100
8,641.7190
17,590.5330
13,340.4930
6,729.6430
Net Income from Continuing & Discontinued Operation
-6,928.3370
-8,374.4150
-17,548.9240
-13,343.1500
-6,364.2300
Normalized Income
-6,916.9938
-8,361.3698
-17,533.3440
-13,333.5788
-6,363.9610
Interest Income
208.9520
289.8460
63.5230
11.1650
37.7780
Net Interest Income
208.9520
289.8460
63.5230
11.1650
37.7780
EBIT
-7,137.9100
-8,641.7190
-17,590.5330
-13,340.4930
-6,400.8420
EBITDA
-6,950.0970
-8,458.2480
-17,472.3450
-13,221.7050
-6,343.2790
Reconciled Cost of Revenue
--
--
--
--
17.6010
Reconciled Depreciation
187.8130
183.4710
118.1880
118.7880
57.5630
Net Income from Continuing Operation Net Minority Interest
-6,928.3370
-8,374.4150
-17,548.9240
-13,343.1500
-6,364.2300
Total Unusual Items Excluding Goodwill
-13.3450
-21.7420
-21.1140
-13.0220
-0.3660
Total Unusual Items
-13.3450
-21.7420
-21.1140
-13.0220
-0.3660
Normalized EBITDA
-6,936.7520
-8,436.5060
-17,451.2310
-13,208.6830
-6,342.9130
Tax Rate for Calcs
0.0002
0.0004
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
-2.0018
-8.6968
-5.5340
-3.4508
-0.0970
9/30/2020 - 6/21/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHGE BiomX Inc.
0.7698
-1.32%
BRTX BioRestorative Therapies, Inc.
1.6100
-2.42%
SILO Silo Pharma, Inc.
1.1400
-2.54%
PSTV Plus Therapeutics, Inc.
1.2865
-9.40%
EPRX Eupraxia Pharmaceuticals Inc.
3.1086
-1.63%
VIRX Viracta Therapeutics, Inc.
0.1820
-4.46%
PALI Palisade Bio, Inc.
2.5090
-1.61%
TNGX Tango Therapeutics, Inc.
3.6150
+11.57%
INAB IN8bio, Inc.
0.3190
-4.41%
ADTX Aditxt, Inc.
0.3950
-16.84%